Mitsuo Terada, MD, PhD@乳腺科医· @MamMa_mimumemo · X·· 2 天前评分45
正文
DESTINY-breast11のMRIとpCRの関係性についての解析。
MRIベースの変化では、思ったよりもpCRの予測ができず、という印象。
#ESMO26
481 浏览 · 5 赞 · 2 转发 · 0 回复
会议摘要
543RO按 Rapid oral: Breast cancer, early stage 对上
DESTINY-Breast11: MRI-assessed objective responses during neoadjuvant treatment (NAT) with trastuzumab deruxtecan (T-DXd) followed by paclitaxel + trastuzumab + pertuzumab (THP) vs dose-dense doxorubicin + cyclophosphamide followed by THP (
https://esmocongress.esmo.org来源：Mitsuo Terada, MD, PhD@乳腺科医 · x.com